The main pathway of galactose metabolism is the Leloir pathway; humans and other species, however, have been noted to contain several alternate pathways, such as the De Ley Doudoroff pathway. The Leloir pathway consists of the latter stage of a two-part process that converts β-D-galactose to UDP-glucose. The initial stage is the conversion of β-D-galactose to α-D-galactose by the enzyme, mutarotase (GALM). The Leloir pathway then carries out the conversion of α-D-galactose to UDP-glucose via three principle enzymes. Galactokinase (GALK) phosphorylates α-D-galactose to galactose-1-phosphate, or Gal-1-P. Galactose-1-phosphate uridyltransferase (GALT) then transfers a UMP group from UDP-glucose to Gal-1-P to form UDP-galactose. Finally, UDP galactose-4’-epimerase (GALE) interconverts UDP-galactose and UDP-glucose, thereby completing the pathway.
Organism species: Pan-species (General)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | CPK543Ge11 | BSA Conjugated D-Galactose (D-Gal) | Immunogen; SDS-PAGE; WB. |
Antibodies | PAK543Ge01 | Polyclonal Antibody to D-Galactose (D-Gal) | WB; IHC; ICC; IP. |
Assay Kits | n/a | CLIA Kit for D-Galactose (D-Gal) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for D-Galactose (D-Gal) | ELISA Kit Customized Service Offer |